- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-PD-L1 Antibody
Total 103158 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHepatocellular Carcinoma | Graft Rejection | Immunotherapy | Immune Checkpoint InhibitorChina
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Tongji HospitalNational Natural Science Foundation of ChinaRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant TherapiesChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingEsophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
Swiss Group for Clinical Cancer ResearchCompletedNSCLC Non-small Cell Lung CancerSwitzerland
-
Shanghai Zhongshan HospitalRecruiting
-
Thomas MarronRecruiting
-
Sichuan UniversityNot yet recruitingAdvanced Solid TumorChina
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, GermanyCompleted
-
Peking Union Medical College HospitalRecruitingHepatocellular CarcinomaChina
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.Terminated
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsRecruitingOncology | NSCLC Stage IV | NSCLC, Stage IIINorway
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck CancerChina
-
The Second Hospital of Nanjing Medical UniversityUnknownPrimary Hepatocellular Carcinoma
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal NeoplasmsChina
-
Herlev and Gentofte HospitalUniversity of CopenhagenCompleted
-
SparX Biotech(Jiangsu) Co., Ltd.RecruitingSolid Tumor | CRC | HNSCC | RCCUnited States
-
ARCAGY/ GINECO GROUPAstraZenecaActive, not recruiting
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
Sichuan UniversityRecruitingMalignant Ascites | Malignant Peritoneal Effusion | Serous Cavity MetastatisesChina
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Chinese PLA General HospitalRecruitingPancreatic Cancer | Biliary Tract CancerChina
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Eli Lilly and CompanyCompletedAdvanced CancerBelgium, United States, Korea, Republic of, Australia, France
-
Eastern Hepatobiliary Surgery HospitalRecruiting
-
Groupe Hospitalier Pitie-SalpetriereInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedAutoimmune Diseases | Endocrine System Diseases | Cancer | Arthritis | Myositis | Neuropathy | Cardiac Disease | OphthalmopathyFrance
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
Lene Meldgaard KnudsenIO BiotechTerminatedSmoldering Multiple MyelomaDenmark
-
Peking University Cancer Hospital & InstituteRecruitingUnresectable Hepatocellular CarcinomaChina
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
National Institute for Tuberculosis and Lung Diseases...SuspendedInterstitial Lung Disease | Lung Neoplasm MalignantPoland
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Peking Union Medical College HospitalRecruiting
-
Dragonboat Biopharmaceutical Company LimitedShanghai East HospitalUnknown
-
Naestved HospitalRecruitingNon-small Cell Lung Cancer | Malignant Pleural EffusionDenmark
-
ImmunityBio, Inc.Active, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability | Mismatch Repair DeficiencyUnited States
-
Lene Meldgaard KnudsenCompleted
-
Stanford UniversityTerminatedMerkel Cell CarcinomaUnited States
-
Daniela Matei, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedEndometrial Cancer | Endometrial AdenocarcinomaUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Genentech, Inc.Completed
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingNon-small Cell Lung Cancer | Advanced Lung Carcinoma